Health & Nutrition

bg
Merck lowers profit outlook, partly due to $200 million expected tariff hit

Merck lowers profit outlook, partly due to $200 million...

Merck said the expected tariff charge primarily reflects levies between the U.S....

bg
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

Bristol Myers Squibb tops quarterly estimates, hikes outlook...

The guidance revisions include the estimated impact of current tariffs on U.S. products...

bg
Why Use Stents When They Don’t Work? 

Why Use Stents When They Don’t Work? 

Again and again, studies have shown that doctors tend to make clinical decisions...

bg
Danaher's quarterly results show signs of life, and the struggling stock soars

Danaher's quarterly results show signs of life, and the...

Count us among the Danaher investors breathing a sigh of relief.

bg
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma

Healthy Returns: Trump seeks to change Medicare drug price...

Trump proposed a change to Medicare price talks that has long been sought after...

bg
FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snacks

FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles...

The FDA is phasing out the use of petroleum-based synthetic dyes in food and drinks.

bg
Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly sues four telehealth sites selling compounded...

Eli Lilly & Co. is suing four telehealth companies selling compounded versions...

bg
Do Heart Stents Benefit Angina Chest Pain? 

Do Heart Stents Benefit Angina Chest Pain? 

Sham surgery trials prove that procedures like non-emergency stents offer no benefit...

bg
These are the 4 biggest things we're watching in the stock market in the week ahead

These are the 4 biggest things we're watching in the stock...

First-quarter earnings season picks up speed inside our portfolio and outside of...

bg
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%

Eli Lilly’s weight loss pill succeeds in first late-stage...

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new,...